Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
2330 | 2279 | 41.6 | 77% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
54 | 3 | ASTHMA//RESPIRATORY SYSTEM//ALLERGY | 90590 |
206 | 2 | CHRONIC OBSTRUCTIVE PULMONARY DISEASE//COPD//RESPIRATORY SYSTEM | 21076 |
2330 | 1 | TIOTROPIUM//INDACATEROL//COPD | 2279 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | TIOTROPIUM | authKW | 3049076 | 12% | 82% | 279 |
2 | INDACATEROL | authKW | 1145889 | 4% | 88% | 97 |
3 | COPD | authKW | 933719 | 29% | 11% | 660 |
4 | LONG ACTING MUSCARINIC ANTAGONIST | authKW | 724346 | 2% | 97% | 56 |
5 | BRONCHODILATOR | authKW | 706378 | 9% | 25% | 212 |
6 | P MED DEV | address | 560759 | 3% | 70% | 60 |
7 | VILANTEROL | authKW | 510350 | 2% | 95% | 40 |
8 | LABA | authKW | 487333 | 2% | 74% | 49 |
9 | CHRONIC OBSTRUCTIVE PULMONARY DISEASE | authKW | 486158 | 22% | 7% | 500 |
10 | INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE | journal | 470050 | 8% | 19% | 187 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Respiratory System | 112966 | 58% | 1% | 1312 |
2 | Critical Care Medicine | 3543 | 8% | 0% | 182 |
3 | Pharmacology & Pharmacy | 3125 | 23% | 0% | 531 |
4 | Medicine, General & Internal | 1779 | 14% | 0% | 324 |
5 | Cardiac & Cardiovascular System | 921 | 9% | 0% | 207 |
6 | Allergy | 619 | 3% | 0% | 60 |
7 | Primary Health Care | 536 | 2% | 0% | 37 |
8 | Health Care Sciences & Services | 252 | 3% | 0% | 61 |
9 | Health Policy & Services | 212 | 2% | 0% | 42 |
10 | Chemistry, Medicinal | 164 | 3% | 0% | 75 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | P MED DEV | 560759 | 3% | 70% | 60 |
2 | UNIT P CLIN PHARMACOL | 140935 | 1% | 48% | 22 |
3 | TA P DIS | 111637 | 0% | 83% | 10 |
4 | UNIT PNEUMOL ALLERGOL | 98628 | 1% | 41% | 18 |
5 | P IMMUNOINFLAMMAT | 85736 | 0% | 80% | 8 |
6 | P DEV | 83467 | 0% | 69% | 9 |
7 | MED EVALUAT UNIT | 82863 | 1% | 25% | 25 |
8 | P PHARMACOL UNIT | 82054 | 0% | 88% | 7 |
9 | CHAIR P MED | 66974 | 0% | 50% | 10 |
10 | UNIV MED GIESSEN MARBURG | 64671 | 1% | 37% | 13 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE | 470050 | 8% | 19% | 187 |
2 | RESPIRATORY MEDICINE | 100632 | 9% | 4% | 199 |
3 | COPD-JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE | 83083 | 3% | 10% | 62 |
4 | PULMONARY PHARMACOLOGY & THERAPEUTICS | 67058 | 4% | 6% | 86 |
5 | RESPIRATORY RESEARCH | 50394 | 4% | 5% | 82 |
6 | THERAPEUTIC ADVANCES IN RESPIRATORY DISEASE | 26928 | 1% | 11% | 18 |
7 | NPJ PRIMARY CARE RESPIRATORY MEDICINE | 26274 | 1% | 11% | 18 |
8 | PRIMARY CARE RESPIRATORY JOURNAL | 22199 | 1% | 8% | 20 |
9 | EXPERT REVIEW OF RESPIRATORY MEDICINE | 18415 | 1% | 6% | 24 |
10 | EUROPEAN RESPIRATORY JOURNAL | 17140 | 5% | 1% | 108 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | TIOTROPIUM | 3049076 | 12% | 82% | 279 | Search TIOTROPIUM | Search TIOTROPIUM |
2 | INDACATEROL | 1145889 | 4% | 88% | 97 | Search INDACATEROL | Search INDACATEROL |
3 | COPD | 933719 | 29% | 11% | 660 | Search COPD | Search COPD |
4 | LONG ACTING MUSCARINIC ANTAGONIST | 724346 | 2% | 97% | 56 | Search LONG+ACTING+MUSCARINIC+ANTAGONIST | Search LONG+ACTING+MUSCARINIC+ANTAGONIST |
5 | BRONCHODILATOR | 706378 | 9% | 25% | 212 | Search BRONCHODILATOR | Search BRONCHODILATOR |
6 | VILANTEROL | 510350 | 2% | 95% | 40 | Search VILANTEROL | Search VILANTEROL |
7 | LABA | 487333 | 2% | 74% | 49 | Search LABA | Search LABA |
8 | CHRONIC OBSTRUCTIVE PULMONARY DISEASE | 486158 | 22% | 7% | 500 | Search CHRONIC+OBSTRUCTIVE+PULMONARY+DISEASE | Search CHRONIC+OBSTRUCTIVE+PULMONARY+DISEASE |
9 | LONG ACTING BRONCHODILATORS | 469155 | 2% | 85% | 41 | Search LONG+ACTING+BRONCHODILATORS | Search LONG+ACTING+BRONCHODILATORS |
10 | ACLIDINIUM | 458499 | 2% | 93% | 37 | Search ACLIDINIUM | Search ACLIDINIUM |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | MONTUSCHI, P , CIABATTONI, G , (2015) BRONCHODILATING DRUGS FOR CHRONIC OBSTRUCTIVE PULMONARY DISEASE: CURRENT STATUS AND FUTURE TRENDS.JOURNAL OF MEDICINAL CHEMISTRY. VOL. 58. ISSUE 10. P. 4131 -4164 | 135 | 81% | 17 |
2 | KEW, KM , DIAS, S , CATES, CJ , (2014) LONG-ACTING INHALED THERAPY (BETA-AGONISTS, ANTICHOLINERGICS AND STEROIDS) FOR COPD: A NETWORK META-ANALYSIS.COCHRANE DATABASE OF SYSTEMATIC REVIEWS. VOL. . ISSUE 3. P. - | 172 | 75% | 12 |
3 | MELANI, AS , (2015) LONG-ACTING MUSCARINIC ANTAGONISTS.EXPERT REVIEW OF CLINICAL PHARMACOLOGY. VOL. 8. ISSUE 4. P. 479 -501 | 122 | 91% | 1 |
4 | FUSO, L , MORES, N , VALENTE, S , MALERBA, M , MONTUSCHI, P , (2013) LONG-ACTING BETA-AGONISTS AND THEIR ASSOCIATION WITH INHALED CORTICOSTEROIDS IN COPD.CURRENT MEDICINAL CHEMISTRY. VOL. 20. ISSUE 12. P. 1477 -1495 | 97 | 70% | 20 |
5 | CAZZOLA, M , BEEH, KM , PRICE, D , ROCHE, N , (2015) ASSESSING THE CLINICAL VALUE OF FAST ONSET AND SUSTAINED DURATION OF ACTION OF LONG-ACTING BRONCHODILATORS FOR COPD.PULMONARY PHARMACOLOGY & THERAPEUTICS. VOL. 31. ISSUE . P. 68 -78 | 82 | 79% | 6 |
6 | MATERA, MG , ROGLIANI, P , CAZZOLA, M , (2014) MUSCARINIC RECEPTOR ANTAGONISTS FOR THE TREATMENT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE.EXPERT OPINION ON PHARMACOTHERAPY. VOL. 15. ISSUE 7. P. 961 -977 | 86 | 82% | 4 |
7 | KEATING, GM , (2012) TIOTROPIUM BROMIDE INHALATION POWDER A REVIEW OF ITS USE IN THE MANAGEMENT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE.DRUGS. VOL. 72. ISSUE 2. P. 273 -300 | 69 | 96% | 31 |
8 | KEW, KM , SENIUKOVICH, A , (2014) INHALED STEROIDS AND RISK OF PNEUMONIA FOR CHRONIC OBSTRUCTIVE PULMONARY DISEASE.COCHRANE DATABASE OF SYSTEMATIC REVIEWS. VOL. . ISSUE 3. P. - | 78 | 78% | 13 |
9 | TASHKIN, DP , FABBRI, LM , (2010) LONG-ACTING BETA-AGONISTS IN THE MANAGEMENT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE: CURRENT AND FUTURE AGENTS.RESPIRATORY RESEARCH. VOL. 11. ISSUE . P. - | 82 | 74% | 53 |
10 | TASHKIN, DP , FERGUSON, GT , (2013) COMBINATION BRONCHODILATOR THERAPY IN THE MANAGEMENT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE.RESPIRATORY RESEARCH. VOL. 14. ISSUE . P. - | 59 | 82% | 55 |
Classes with closest relation at Level 1 |